Company Filing History:
Years Active: 1989
Title: Barbara J Dalton: Innovator in Immunomodulation
Introduction
Barbara J Dalton is a notable inventor based in Philadelphia, PA (US). She has made significant contributions to the field of immunology, particularly through her innovative work in immunomodulation. Her research has led to advancements that could potentially improve immune responses in humans and animals.
Latest Patents
Barbara J Dalton holds a patent for an immunomodulating pharmaceutical composition. This composition comprises an effective, leukocyte interferon production-inducing amount of NS1 and a pharmaceutically acceptable carrier or diluent. The patent also details a method of modulating the immune response in a human or other animal by inducing the production of leukocyte IFN through the administration of an effective amount of NS1.
Career Highlights
Throughout her career, Barbara has been associated with SmithKline Beecham Corporation, where she has applied her expertise in immunology. Her work has been instrumental in developing new therapeutic approaches that leverage the immune system's capabilities.
Collaborations
Barbara has collaborated with various professionals in her field, including her coworker Robert Charles Rees. Their joint efforts have contributed to the advancement of immunological research and the development of innovative therapies.
Conclusion
Barbara J Dalton's contributions to immunomodulation highlight her role as a pioneering inventor in the field of immunology. Her patent and work at SmithKline Beecham Corporation reflect her commitment to advancing medical science and improving health outcomes.